Cytokine regulation of metalloproteinase gene expression
Tóm tắt
Matrix metalloproteinases belong to a family of zinc‐dependent enzymes capable of degrading extracellular matrix and basement membrane components. Their expression is greatly modulated by cytokines and growth factors and involves the gene products of the Fos and Jun families of oncogenes. After extra(peri)cellular activation, their activity can be further controlled by specific tissue inhibitors of metalloproteinases. A correct balance between these regulatory mechanisms is necessary to ensure matrix remodeling in normal physiological processes such as embryonic development, but the overexpression of these enzymes may initiate or contribute to pathological situations such as cartilage degradation in rheumatoid arthritis or to tumor progression and metastasis. Delineation of the mechanisms of metalloproteinase and metalloproteinase inhibitors gene expression, understanding of their mode of interactions, and characterization of their patterns of expression in various tissues in normal and pathological states will lead to new therapeutic strategies to counteract the deleterious effects of matrix metalloproteinases in human disease.
Từ khóa
Tài liệu tham khảo
Conca W, 1991, An interleukin‐1β point mutant demonstrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expression, J Biol Chem, 266, 16265, 10.1016/S0021-9258(18)55287-X
Corcoran ML, 1992, Interleukin‐4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92‐kDa type IV collagenase/gelatinase production by human monocytes, J Biol Chem, 267, 515, 10.1016/S0021-9258(18)48525-0
Emonard H, 1990, Matrix metalloproteinases: A review, Cell Mol Biol, 36, 131
Emonard HP, 1992, Tumor cell surface‐associated binding site for the Mr 72,000 type IV collagenase, Cancer Res, 52, 5845
Ito A, 1991, Calmodulin differentially modulates interleukin‐1‐induced biosynthesis of tissue inhibitor of metalloproteinases and matrix metalloproteinases in human uterine cervical fibroblasts, J Biol Chem, 266, 13598, 10.1016/S0021-9258(18)92741-9
MauvielA ChenYQ DongW EvansCH UittoJ(in press): Transcriptional interactions of transforming growth factor‐β with pro‐inflammatory cytokines. Interference with the AP‐1 but not with the NF‐κβ trans‐activation pathways.Current Biology.
Mauviel A, 1992, Transcriptional activation of fibroblast collagenase gene expression by a novel lymphokine, leukoregulin, J Biol Chem, 267, 5644, 10.1016/S0021-9258(18)42814-1
Pyke C, 1991, Urokinase‐type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas, Am J Pathol, 138, 1059
Salo T, 1991, Transforming growth factor‐β1 up‐regulates type IV collagenase expression in cultured human keratinocytes, J Biol Chem, 266, 11436, 10.1016/S0021-9258(18)98977-5
Wilkinson DG, 1989, Tissue‐specific expression of c‐jun and jun‐B during organogenesis in the mouse, Development, 106, 465, 10.1242/dev.106.3.465